Company / Book Value per Share
RAPT Therapeutics, Inc. Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.659
FY2024
5-year range
$3.835 / $7.534
FY2020-FY2024
Trend
+21.5%
vs FY2023
Sector context
#106 of 207
Health Care
What the data says
At $4.659, RAPT Therapeutics, Inc.'s book value per share ranks #106 of 207 in the Health Care sector. Book Value per Share has fluctuated over the past 7 years, ranging from -$156.058 in FY2018 to $16.823 in FY2019.
Based on SEC 10-K filings.
$4.659 in FY2024 with a 5-year CAGR of -22.6%.
Declined from $7.534 to $4.659 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- -22.6%
- 10-Year CAGR
- -
Sector benchmark
#106 of 207 in Health CareTop 51% of 207This company $4.659 Sector average $208.468
▼
-97.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -22.6%, indicating a declining trend.
- In FY2024, book value per share increased 21.5% year-over-year.
- Ranks #106 out of 207 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.659 | +21.5% |
| FY2023 | $3.835 | -49.1% |
| FY2022 | $7.534 | +10.7% |
| FY2021 | $6.805 | +57.6% |
| FY2020 | $4.317 | -74.3% |
| FY2019 | $16.823 | +110.8% |
| FY2018 | -$156.058 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026